| 000 | 01251 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517154103.0 | ||
| 264 | 0 | _c20170704 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1179-1950 | ||
| 024 | 7 |
_a10.1007/s40265-017-0755-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFlamant, Mathurin | |
| 245 | 0 | 0 |
_aAdvances in the Development of Janus Kinase Inhibitors in Inflammatory Bowel Disease: Future Prospects. _h[electronic resource] |
| 260 |
_bDrugs _cJul 2017 |
||
| 300 |
_a1057-1068 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aJanus Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aSTAT Transcription Factors _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aRigaill, Josselin | |
| 700 | 1 | _aPaul, Stephane | |
| 700 | 1 | _aRoblin, Xavier | |
| 773 | 0 |
_tDrugs _gvol. 77 _gno. 10 _gp. 1057-1068 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40265-017-0755-8 _zAvailable from publisher's website |
| 999 |
_c27190585 _d27190585 |
||